Coloplast A/S
Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST
Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST
Tuesday, 6 May 2025 at 11.00 - 12.00am CEST
In connection with the publication of Coloplast’s interim financial results for H1 2024/25, to be released same day around 07.30am CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Vice President, Investor Relations
Simone Dyrby Helvind - Senior Manager, Investor Relations
Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here
Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here
For more information, please contact:
Aleksandra Dimovska - Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com
Simone Dyrby Helvind - Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: dksdk@coloplast.com
Julie Sommer Müggler - Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: dkjusm@coloplast.com
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S12.5.2025 08:01:21 CEST | Press release
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
Aspo Plc12.5.2025 08:00:00 CEST | Press release
Aspo Plc’s Interim Report, January 1 – March 31, 2025: Strong start for year 2025 with continued profitability improvement
KBC Groep12.5.2025 08:00:00 CEST | Press release
KBC Group: Regulated information – 12 May 2025 before trading hours (08h00)
Norsk Hydro12.5.2025 08:00:00 CEST | Press release
Norsk Hydro: Ex-dividend NOK 2.25 today
Trifork Group AG12.5.2025 07:30:26 CEST | Press release
27/2025・Trifork Group: Weekly report on share buyback
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom